Selected article for: "atherosclerotic plaque and plaque progression"

Author: Kowara, Michal; Borodzicz-Jazdzyk, Sonia; Rybak, Karolina; Kubik, Maciej; Cudnoch-Jedrzejewska, Agnieszka
Title: Therapies Targeted at Non-Coding RNAs in Prevention and Limitation of Myocardial Infarction and Subsequent Cardiac Remodeling—Current Experience and Perspectives
  • Cord-id: ien2gy2e
  • Document date: 2021_5_27
  • ID: ien2gy2e
    Snippet: Myocardial infarction is one of the major causes of mortality worldwide and is a main cause of heart failure. This disease appears as a final point of atherosclerotic plaque progression, destabilization, and rupture. As a consequence of cardiomyocytes death during the infarction, the heart undergoes unfavorable cardiac remodeling, which results in its failure. Therefore, therapies aimed to limit the processes of atherosclerotic plaque progression, cardiac damage during the infarction, and subseq
    Document: Myocardial infarction is one of the major causes of mortality worldwide and is a main cause of heart failure. This disease appears as a final point of atherosclerotic plaque progression, destabilization, and rupture. As a consequence of cardiomyocytes death during the infarction, the heart undergoes unfavorable cardiac remodeling, which results in its failure. Therefore, therapies aimed to limit the processes of atherosclerotic plaque progression, cardiac damage during the infarction, and subsequent remodeling are urgently warranted. A hopeful therapeutic option for the future medicine is targeting and regulating non-coding RNA (ncRNA), like microRNA, circular RNA (circRNA), or long non-coding RNA (lncRNA). In this review, the approaches targeted at ncRNAs participating in the aforementioned pathophysiological processes involved in myocardial infarction and their outcomes in preclinical studies have been concisely presented.

    Search related documents:
    Co phrase search for related documents
    • acute phase and adhesion molecule: 1, 2
    • acute phase and liver cell: 1, 2, 3, 4, 5
    • acute phase and local immune response: 1, 2
    • acute phase and local inflammation: 1, 2
    • acute phase and low density: 1, 2
    • acute phase and low density lipoprotein: 1
    • acute phase and low grade level: 1
    • acute phase and low oscillatory: 1
    • acute phase and lv ejection fraction: 1, 2, 3
    • acute phase and macrophage differentiation: 1
    • acute phase and macrophage expression: 1, 2
    • acute phase and macrophage polarization: 1
    • acute phase and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26